Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial To Evaluate Safety and Efficacy of the C2 CyroBalloon™ 180 Ablation System for the Treatment of Dysplastic Barrett's Esophagus: CBAS180 De-escalation Study

NCT03311451 is registered in ClinicalTrials.gov with Merit Medical Systems, Inc. as lead sponsor.

NCT NCT03311451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03311451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial To Evaluate Safety and Efficacy of the C2 CyroBalloon™ 180 Ablation System for the Treatment of Dysplastic Barrett's Esophagus: CBAS180 De-escalation Study
Lead sponsor
Merit Medical Systems, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 16, 2023
Completion date
December 18, 2026
Enrollment
62 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus